TAK1 Regulation of TGF-beta and IL-1 signaling

TAK1 对 TGF-β 和 IL-1 信号传导的调节

基本信息

项目摘要

DESCRIPTION (provided by applicant): Cytokines play important roles in human development and disease. Specificity and cross-talk of cytokine signaling pathways appear to be important for fine-tuning stress responses and cell fate decision during development. Transforming growth factor beta (TGF-beta) is involved in cell growth, differentiation, tissue remodeling, immune response and angiogenesis. Interleukin 1 (IL-1) pathway plays a central role in the generation of inflammatory responses. We have found that both TGF-beta and IL-1 activate TGF-beta activated kinase 1 (TAK1) MAPKKK. Active form of TAK1 can enhance both TGF-beta- and IL-l-dependent transcription. In response to IL-1 stimulation, TAK1 activates transcription factors AP-1 and NF-KappaB. While TGF-6 stimulation does activate TAK1, the role of TAK1 in TGF-beta signaling pathway is not known. Recently, we found that TAK1 associates with a transcriptional repressor SnoN, a negative regulator of TGF-beta signaling. TAK1 induces degradation of SnoN. We hypothesize that TGF-beta activates TAK1 to induce phosphorylation of SnoN and targets SnoN for proteasomal degradation, thereby up-regulating TGF-b signal transduction. In addition, we hypothesize that TGF-beta and IL-1 activate TAK1 in distinct manner via specific scaffold/regulatory proteins to induce their unique cellular responses. Thus, the overall objectives of this proposal are; to delineate the pathway and functional role of TAK1 in TGF-beta signaling and to elucidate the mechanisms through which TAK1 regulates signal pathway specificity. To accomplish these objectives and to test our hypotheses we will: i) determine the mechanism and role of TAK1-induced SnoN degradation in TGF-b signaling pathway; ii) isolate and characterize molecules associated with TAK1 and iii) generate a skin specific knockout of TAK1 to characterize the in vivo role of TAK1 in a tissue in which TGF-beta play important roles. These studies will address unsolved questions regarding the mechanisms of TGF-beta and IL-1 family signaling and will provide an understanding of the physiological function of TAK 1 in vivo.
描述(由申请人提供):细胞因子在人类发育和疾病中发挥重要作用。细胞因子信号通路的特异性和串扰对于发育过程中微调应激反应和细胞命运决定似乎是重要的。转化生长因子β(TGF-β)参与细胞生长、分化、组织重塑、免疫应答和血管生成。白细胞介素1(IL-1)通路在炎症反应的产生中起着核心作用。我们已经发现TGF-β和IL-1都激活TGF-β激活的激酶1(TAK 1)MAPKKK。TAK 1的活性形式可以增强TGF-β和IL-1依赖性转录。响应于IL-1刺激,TAK 1激活转录因子AP-1和NF-κ B。虽然TGF-6刺激确实激活了TAK 1,但TAK 1在TGF-β信号通路中的作用尚不清楚。最近,我们发现TAK 1与转录抑制因子SnoN相关,SnoN是TGF-β信号的负调节因子。TAK 1诱导SnoN的降解。我们假设TGF-β激活TAK 1诱导SnoN磷酸化,并靶向SnoN进行蛋白酶体降解,从而上调TGF-β信号转导。此外,我们假设TGF-β和IL-1通过特定的支架/调节蛋白以不同的方式激活TAK 1,以诱导其独特的细胞反应。因此,本提案的总体目标是:描述TAK 1在TGF-β信号传导中的通路和功能作用,并阐明TAK 1调节信号通路特异性的机制。为了实现这些目标并测试我们的假设,我们将:i)确定TAK 1诱导的SnoN降解在TGF-β信号传导途径中的机制和作用; ii)分离并表征与TAK 1相关的分子;以及iii)产生皮肤特异性TAK 1敲除以表征TAK 1在TGF-β发挥重要作用的组织中的体内作用。这些研究将解决有关TGF-β和IL-1家族信号传导机制的未解决问题,并将提供对TAK 1体内生理功能的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jun Ninomiya-Tsuji其他文献

Jun Ninomiya-Tsuji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jun Ninomiya-Tsuji', 18)}}的其他基金

TAK1 signaling pathways
TAK1信号通路
  • 批准号:
    10318180
  • 财政年份:
    2021
  • 资助金额:
    $ 23.23万
  • 项目类别:
TAK1 signaling pathways
TAK1信号通路
  • 批准号:
    10542715
  • 财政年份:
    2021
  • 资助金额:
    $ 23.23万
  • 项目类别:
TAK1 Signaling Pathways
TAK1 信号通路
  • 批准号:
    10582758
  • 财政年份:
    2021
  • 资助金额:
    $ 23.23万
  • 项目类别:
TAK1 regulation of metabolism
TAK1 代谢调节
  • 批准号:
    9116236
  • 财政年份:
    2015
  • 资助金额:
    $ 23.23万
  • 项目类别:
TAK1 regulation of reactive oxygen species and inflammation
TAK1 对活性氧和炎症的调节
  • 批准号:
    7937866
  • 财政年份:
    2009
  • 资助金额:
    $ 23.23万
  • 项目类别:
TAK1 signaling network in tissue homeostasis
TAK1 信号网络在组织稳态中的作用
  • 批准号:
    8247818
  • 财政年份:
    2004
  • 资助金额:
    $ 23.23万
  • 项目类别:
TAK1 signaling network in tissue homeostasis
TAK1 信号网络在组织稳态中的作用
  • 批准号:
    8283462
  • 财政年份:
    2004
  • 资助金额:
    $ 23.23万
  • 项目类别:
TAK1 Regulation of TGF-beta and IL-1 signaling
TAK1 对 TGF-β 和 IL-1 信号传导的调节
  • 批准号:
    6779613
  • 财政年份:
    2004
  • 资助金额:
    $ 23.23万
  • 项目类别:
TAK1 Regulation of TGF-beta and IL-1 signaling
TAK1 对 TGF-β 和 IL-1 信号传导的调节
  • 批准号:
    7046017
  • 财政年份:
    2004
  • 资助金额:
    $ 23.23万
  • 项目类别:
ROLE OF TAK1 IN RANKL SIGNALING PATHWAY
TAK1 在 RANKL 信号通路中的作用
  • 批准号:
    6929234
  • 财政年份:
    2004
  • 资助金额:
    $ 23.23万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了